APSR2026-250

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-030
P107
 
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Resti Yudhawati * Universitas Airlangga Pulmonology and Respiratory Medicine, Faculty of Medicine Surabaya Indonesia Dr. Soetomo General Academic Hospital Pulmonology and Respiratory Medicine Surabaya Indonesia Universitas Airlangga Teaching Hospital Pulmonology and Respiratory Medicine Surabaya Indonesia
Helmia Hasan - Dr. Soetomo General Academic Hospital Pulmonology and Respiratory Medicine Surabaya Indonesia
Garinda Alma Duta - Dr. Soetomo General Academic Hospital Pulmonology and Respiratory Medicine Surabaya Indonesia
Faradila Nur Aini - Dr. Soetomo General Academic Hospital Pulmonology and Respiratory Medicine Surabaya Indonesia
Dwi Wahyu Indrawanto - Dr. Soetomo General Academic Hospital Pulmonology and Respiratory Medicine Surabaya Indonesia
Wiwin Is Effendi - Universitas Airlangga Pulmonology and Respiratory Medicine, Faculty of Medicine Surabaya Indonesia Universitas Airlangga Teaching Hospital Pulmonology and Respiratory Medicine Surabaya Indonesia
 
 
 
 
 
 
 
 
 
Presenting Author Details
Resti
Yudhawati
resti-y-m@fk.unair.ac.id
+6289673691726
41-50
Indonesia
Case Report
Persistent Bronchopleural Fistula in Fibrotic Lung Disease During TB Treatment: A Diagnostic Challenge Revealing Fibrotic Hypersensitivity Pneumonitis
Maximum 25 words
Abstract Content
 
 
 
 
In high-burden tuberculosis (TB) countries, fibrotic lung diseases may clinically and radiologically similar to TB, causing major diagnostic ambiguity. Distinguishing fibrotic hypersensitivity pneumonitis (HP) from clinically diagnosed TB with negative molecular and smear sputum examinations, is challenging without microbiological validation. The evaluation and management further complicated by bronchopleural fistula (BPF).
A 60-year-old male farmer with heavy smoking history (±40 years, 2 packs/day) reported worsening dyspnea, productive cough, chest pain, loss of appetite, and weight loss. Subsequent to clinical diagnosis, anti-TB medication were administered. Despite chest tube insertion, the right lung failed to re-expand. Imaging showed persistent hydropneumothorax, while HRCT revealed honeycombing and peribronchiolar fibrosis. Sputum Ziehl–Neelsen staining and Xpert MTB/RIF were negative. Multidisciplinary assessment suggested persistent BPF. Due to dense adhesions, VATS was converted to mini-thoracotomy, confirming BPF at the right upper lobe apex. Adhesiolysis, wedge resection, and fistula repair were performed. Histopathology showed honeycombing and peribronchiolar fibrosis with infiltration of histiocytic, lymphocytes, and macrophages cells, supporting fibrotic HP. Tissue molecular testing for TB was negative.
This case highlights the diagnostic overlap between fibrotic HP and TB in endemic settings, where clinical bias toward TB may impact management decisions. Negative microbiological results do not completely exclude TB, often leading to continuation of therapy while reassessing alternative diagnoses. Persistent air leak may reflect structural fragility of fibrotic lung parenchyma rather than infectious necrosis. Surgical intervention served both therapeutic and diagnostic purposes, providing definitive histopathological and bacteriological clarification. Steroid were not administered since there is no evidence of benefit in fibrotic HP. Additionally, patients were still receiving anti-TB therapy. Antifibrotic therapy was considered but limited by the patient’s financial circumstances.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Fibrotic hypersensitivity pneumonitis; Tuberculosis; Bronchopleural fistula
maximum 3 keywords and no abbreviations, separated by commas
The author(s) report no conflicts of interest in this work.
271